Immunotherapy beyond cellular therapy in follicular lymphoma: A case of complete remission after failure of two CAR-T.

Adam M KaseMohamed A Kharfan-DabajaAndrew DonaldsonJamie ElliottTaimur Sher

Published in: Clinical case reports (2022)

Patients with relapsed follicular lymphoma who do not respond to CAR-T have a poor outcome. We present a case of refractory follicular lymphoma who relapsed after two CAR-T infusions and achieved a complete remission after treatment with obinutuzumab and lenalidomide. This represents a promising treatment option in the post-CAR-T setting.

Keyphrases

multiple myeloma
acute lymphoblastic leukemia
acute myeloid leukemia
hodgkin lymphoma
diffuse large b cell lymphoma
disease activity
chronic lymphocytic leukemia
stem cell transplantation
stem cells
combination therapy
mesenchymal stem cells
replacement therapy
cell therapy